封面
市場調查報告書
商品編碼
2145377

企業影像IT與PACS,展望報告:全球市場結構、預測、競爭趨勢與工作流程貨幣化,2025-2036年

Global Enterprise Imaging IT & PACS Horizon: Market Structure, Forecasts, Competitive Dynamics, and Workflow Monetization, 2025A-2036E

出版日期: | 出版商: Marketstrat, Inc. | 英文 198 Pages; 97 Tables; 34 Figures | 訂單完成後即時交付

價格

報告摘要

Marketstrat® Horizo​​n 的這份報告分析了 2025 年至 2036 年全球企業影像 IT 和醫療圖像管理系統 (PACS) 市場。該報告計算並預測了支援診斷影像檢視、影像存檔、獨立 RIS、放射學報告、影像解釋工作流程、影像交換和病患存取以及 AI編配和管治的軟體和直接相關服務的市場規模。

本報告將預測與影響商業性成果的決策連結起來。具體而言,這包括客戶將首先替換哪些應用程式、供應商如何獲得額外的工作範圍、合約工作何時才能產生效益,以及續約後哪些款項將繼續支付。一般認為,雖然影像解讀平台的初始訂單可能為後續有關歸檔、報告或工作流程的決策鋪平道路,但永續的業務仍取決於交貨的驗收和款項的持續支付。隨著客戶應用程式環境的演變,獨立供應商需要不斷履行跨系統、服務或專業化的角色。

需要解答的主要問題

  • 初始平台協議對未來的購買有何影響?此外,買方在簽署初始合約時,應就後續定價、資料存取和終止條件達成哪些協議?
  • 如果把新收費的功能、從其他供應商遷移過來的付款以及轉移到託管服務的營運任務分開來看,大規模的經常性合約究竟意味著什麼?
  • 在傳統收費系統被取代之後,人工智慧驅動的報告產生和編配可以在哪些領域成為穩定的收入來源?
  • 從企業醫療保健系統到放射科集團和公共影像網路,商業策略應如何根據國家和買家類型而有所不同?
  • 區分「基本面」、「看漲」和「看跌」情境的運作條件是什麼?在什麼徵兆下應該改變市場展望?

市場概覽

本市場定義為外部供應商提供的一般醫學影像應用及直接相關服務(包括供應商提供的託管服務)的收入。臨床人工智慧演算法、專業分析、掃描器及硬體、影像工作站、通用電子健康記錄(EHR)、專科影像以及醫療機構直接支付的基礎設施均不包含在內。從功能、收入確認和區域觀點,所有收入均指同一收入,且與上述總額一致。

成長並非完全由臨床需求驅動。除了從傳統許可經濟模式向訂閱合約的轉變以及付費應用程式的增加外,該預測還高度依賴影像檢查活動、付費保險和定價。如果合約中包含託管服務,或者供應商承擔其他方的費用,則供應商收入可能會增加,因此本報告區分了供應商收入成長和醫療保健系統內部支出的淨成長。

主要市場趨勢

  • 1. 核心影像檢視和歸檔功能仍然是商業性基礎。 PACS 和歸檔決策的絕對商機最大,因此效能、互通性、遷移和支援仍然是重要的商業性因素。
  • 2. 報告功能的出現使得放射科醫師的日常工作面臨更多競爭。現有的報告提供者、企業平台、獨立人工智慧專家和醫療保健公司都在爭奪相同工作流程,而這種競爭的經濟可行性取決於新增費用是在現有費用之上還是取代現有費用。
  • 3. 持續的客戶關係貢獻了大部分收入。訂閱、服務協議和過度使用進一步凸顯了已批准的收費服務、續約時價格的一致性以及付費模組的持續使用的重要性。
  • 4. 模組化入口有助於實現整合。採用有限的檢視器和工作流程可能會增強供應商在未來歸檔決策中的地位。
  • 5. 託管服務正在改變我們對成長的認知。隨著基礎設施責任轉移到應用服務契約,供應商的收入可能會增加,而買方的總營運成本可能會發生變化。
  • 6. 您的交付能力決定了您發展的品質。隨著合約範圍的擴大,您在遷移、支援和整合方面的義務也會增加;因此,可復現的部署將成為一項競爭優勢。

目錄

第1章摘要整理

  • 管理概述
  • 市場成長集中的地區
    • 全球職能展望
  • 服務義務變化促使經營模式發生變化
    • 長期合作關係貢獻了大部分收入。
    • 選定的替代項目可能會促使產業進一步重組。
    • 報告方法和託管格式的變更會改變我們對成長的解讀方式。
  • 競爭格局展望:七大叢集,重疊的購買決策
    • 競爭格局概述
  • 區域優先事項:保持規模並確保合格。
    • 區域市場展望
  • 情境與風險:機會轉化為利潤的程度取決於執行能力。
    • 全球情勢展望
  • 經營團隊的建議和具體行動
  • 未來12-24個月需要關注的徵兆
  • 估算範圍和置信水平
  • 給經營團隊的建議

第2章:調查方法

  • 目標和市場定義
  • 銷售收入範圍和總結規則
  • 過去的市場結構
  • 國家組成及年成長率
  • 合約的經濟層面及合約執行
  • 按功能和收入確認流進行分析
  • 人工智慧重複勞動和費用重新分配
  • 情景與不確定性
  • 負責處理和分析證據
  • 解釋

第3章:全球市場的結構與展望

  • 市場展望
    • 全球市場概況
  • 核心評估和存檔領域蘊藏著巨大的商機。
    • 按功能分類的全球市場
  • 報告領域的競爭可能會促使現有支出的重新分配。
  • 經常性收入確認的重要性日益凸顯。
    • 按確認法確認收入
  • 根據地理規模和成長率的不同,需要採取不同的商業性優先事項。
  • 敏感性分析可以識別出最關鍵的業務風險。
  • 戰略意義
  • 整體結論
  • 策略建議:續約決定將影響企業獲得更廣泛收入來源的機會。
  • 框架結構及其在決策中的應用
  • M3市場動能矩陣:規模與成長的不同商業性作用
    • 功能動力和對成長的貢獻
  • M-TEM:即使技術已經成熟,其交付模式可能仍不成熟。
  • T-DIC:三個條件過渡期
  • 解決方案部署與成長:使銷售方法與買方的實際挑戰保持一致
  • 產生收入與取代現有收入:一座至關重要的商業性橋樑
  • 雲端合約:區分供應商收入和客戶營運成本。
  • 升級市場情報和逐步部署方案:根據準備確定優先承諾
  • 生態系內的協作:夥伴關係的價值在於營運責任。
  • 策略穩健性:在所有情況下都有效的措施。

第4章:競爭叢集、關鍵企業與商業策略

  • 競爭問題:控制權分散在整個影像工作流程中。
  • 競爭叢集和目標公司
    • 競爭叢集圖和目標公司
  • 歷史收入規模:可提供有用的背景信息,但排名準確性有限。
    • 預估的歷史合格核心銷售額
  • 競爭對手的地位難以撼動的原因,以及仍存在進入空間的領域。
  • GTM成長與成熟度矩陣:部分公司的定位
    • 競賽資料集及放置理由
    • 關於競爭環境和成長/成熟的關鍵點
  • 競爭對手叢集1:企業級醫療影像平台供應商
    • Pro Medicus/Visage:領導者環境支援業務擴展,但每個模組都需要付費實施。
    • Sectra:隨著發展成為企業規模,策略影響力和營運責任也不斷增加。
    • 愛克發醫療保健:遷移品質比雲端採用的標籤更重要。
    • 飛利浦:一個強大的資訊平台需要專門針對醫療影像的銷售帳戶。
    • 富士軟片:雖然業務的廣度和區域佈局支持擴張,但收入規模仍然很重要。
    • GE醫療傳統影像IT:現有部署的連續性仍然是一個明顯的商業性挑戰。
    • Intelerad:收購了擁有良好業績記錄的應用平台。
    • 西門子醫療:定義軟體目標時,不應考慮與掃描器的關係。
    • 合併:隨著雲端運算技術的進步,現有系統與雲端運算之間簡單的二元對立已經不再成立。
  • 競爭叢集2:區域整合 PACS/RIS 與細分市場供應商
    • Dedalus Imaging IT:本地工作流程支援公司間關係
    • INFINITT:全球應用營收需要全球競爭觀點。
    • TechMatrix/PSP:由於雲端包裝,採購單位已變更。
    • Telemis:本地化部署可以在廣泛的平台市場中保持價值。
    • Neagen/Vitec:本地影像技術水準和團隊規模是單獨的評估標準。
    • IMEXHS:將軟體與專業影像分析分開是一個商業性意義的關鍵因素。
    • 柯尼卡美能達影像IT:整合與專家夥伴關係並存
    • 佳能醫療影像IT:共用影像管理應與專業領域分析分開處理。
    • RamSoft:針對特定作業系統環境的綜合工作流程提案
    • 諾瓦拉德:在更廣泛的產品組合中保持通用的成像領域。
    • CGM/VISUS:在進行影像比較時,應將 JiveX 與其母公司的 EHR 業務分開考慮。
    • NEXUS/CHILI:醫療影像業務應在應用層級進行評估。
    • Softway Medical Imaging:應該區分面向社區的診斷影像業務和針對綜合醫院的軟體業務。
    • Maincare:保留的應用程式和整合的價值應與轉嫁收入區分開來。
    • PaxeraHealth:需要將廣泛的業務範圍轉化為一個可複製的實施系統。
    • 影像資訊系統:即使在有限的替換項目中,應用專家也能保持其相關性。
    • 東軟影像軟體:解讀評分前請先辨識軟體營業單位。
    • 勝訴案例:某地區供應商故意限制其財務索賠。
    • B-Soft:在本地醫療 IT 的背景下,有必要專門為診斷成像定義邊界。
    • 迅飛的醫療影像業務:其定位和產品範圍仍然有限。
    • TechHeim:市佔率尚未估算,但以下是一些參與企業。
    • Medsynaptic:多種替代給藥方式支持其獨特的商業化模式。
    • Pixeon:區域一體化和模組化成像在巴西的採購中非常重要。
    • MV影像:整合臨床軟體需要嚴格的收入分成模式。
    • AKGUN影像:醫療保健機構間的合作功能應與地域性收入歸屬區分開來。
    • Lifetrack Medical Systems:分散式影像判讀需要可行的應用程式配置。
    • BMD 軟體/PACScenter:跨醫療機構和網路配置的基於 Web 的診斷影像。
  • 競爭叢集3:歸檔、互通性、影像存取和通用資料工作流程
    • Hyland
    • Mach7
    • Optum/Legacy 成像系統變更:連續性和所有權標籤不應掩蓋產品的範圍。
    • Enlitic 的通用資料工作流程:透過平台替換,即使是具有挑戰性的資料處理也可以保留其價值。
    • PocketHealth:基於存取權限和付費實現方式的基本要素有所不同。
  • 競爭叢集4:報表、語音辨識與影像解讀生產力提升解決方案供應商
    • 微軟/Nuance:一家積極進取、實力雄厚的公司,在報表領域擁有穩固的地位。
    • Rad AI:獨立新聞報道企業必須透過現有供應商的支持來維持其價值。
    • Solventum的診斷放射學報告業務:大型軟體企業中的專業領域
    • NewVue:影像解讀服務可透過平台合作夥伴銷售。
    • 新燈籠:必須明確區分平台提案和透過付費服務實現規模化發展的記錄。
    • RADPAIR:在一群小規模供應商中,一家具有明顯辨識度的報告提供者。
    • nVoq:語音科技合作夥伴,其角色比簽約的醫療影像平台更為有限。
  • 競爭叢集5:整合影像解讀平台和基於提供者的技術業務
    • Sirona:國際合約具有戰略意義,但其實用化仍是真正的考驗。
    • RadNet/DeepHealth:需要單獨進行會計處理,同時考慮內部績效與外部需求。
    • Mosaic/放射學合作夥伴:內部規模提供了一個發展環境,但不會產生全部外部收入。
  • 競爭叢集6:人工智慧編配、市場與管治平台
    • deepc:整合後的業務提案對於維護管治至關重要。
    • Incepto:分銷和服務成本應與應用程式的總轉售價值分開考慮。
    • CARPL.ai:目錄的廣度需要付費的管治措施。
    • Ferrum Health:只有當分母正確時,實施結果才有用。
    • Aidoc 的合格平台活動:廣泛的臨床覆蓋範圍並不構成核心市場的分母。
    • 拜耳/布萊克福德:平台永續性的歷史案例研究
  • 競爭叢集7:電子病歷、雲端運算和基礎設施相關領域
    • Epic:EHR 工作流程會影響影像設備的採購,但不會定義整個影像合約。
    • Oracle Health:與 EHR 和商業 PACS 解決方案相鄰,需要雙重支援。
    • 亞馬遜網路服務:基礎設施可以改變應用程式的經濟效益,而無需取代它們。
    • 微軟 Azure:需要將人們與基礎架構的關係與 Nuance 的應用程式收入脫鉤。
    • Google Cloud:可互通的資訊服務是基礎層。
  • 五個改變商業性解讀的競爭案例研究
  • 相互矛盾的觀點,這些觀點可能加強或削弱這一論點。
  • 每位參與者的商業性優先事項
  • 實用型競爭對手儀表板
  • 關於競爭的結論

第5章 區域與國家特定市場分析

  • 區域尺度與地方商業化機制
    • 區域市場展望
    • 亞太地區的絕對成長和組成變化
    • 如何解讀國別分析
    • 不同地區商業化的典型案例
  • 北美洲
    • 區域情境參考資料
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 愛爾蘭共和國
    • 北歐國家
    • 比荷盧經濟聯盟
    • 中歐/東歐
    • 其他歐洲國家
  • 亞太地區
    • 參考區域情景
    • 中國當地
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 紐西蘭
    • 新加坡/台灣
    • 東南亞(不包括新加坡)
    • 南亞(不包括印度)
    • 其他亞太地區
  • 拉丁美洲
    • 區域情境參考
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東和非洲
    • 區域情境參考資料
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他海灣合作理事會國家
    • 南非
    • 北非
    • 其他中東和非洲地區
  • 跨區域策略一體化
    • 影像可用性和應用程式替換應根據具體情況進行評估。
    • 當地供應商不僅會改變名義價格,還會改變實際的包裝內容。
    • 規模化和成長需要做出涉及兩方面的資源決策。
    • 改變地理解釋的證據
  • 地理結論

第6章:技術、商業化與營運經濟學

  • 商業性問題:供應義務決定成長質量
  • 架構選擇應從替換邊界開始。
    • 建築風格的選擇及其所帶來的義務
  • 買家的獨特組成決定了銷售策略。
  • 在設定定價基準之前,必須先確定一個通用的價格範圍。
    • 精選合約範例及其解讀
  • 最低保證金額及任何超出部分將作為需求風險分配。
  • 四個商業性時間框架解釋了為什麼合約價值與收入之間存在差異。
  • 實施工作應作為一系列已通過核准的工作量進行管理。
    • 建議的驗收時間表
  • 雲端採購需要兩種經濟方案。
    • 明確買賣雙方的義務。
  • 貨幣化報告需要進行遷移後支出測試。
  • 是否增加付費模組應在合約續約時進行評估。
  • 獨立編配需要持續投入和穩定的資金支持。
  • 互通性、服務連續性和管治受到合約層面的影響。
  • 應根據相應的基本客群來評估客戶維繫率和單位經濟效益。
    • 提案的營運審查措施
  • 按競爭叢集的商業化優先事項
  • 本節結論

第7章:情境展望、策略重點與行動計劃

  • 策略建議:PACE 實現產生收入所需條件的方法
    • 全球市場概況
  • 情境分析關注的是改變商業環境,而不是歷史基準。
    • 區分每種情境的關鍵業務假設
    • 基本案例:協作執行將創造一個大規模、更永續的市場。
    • 樂觀情境:快速部署必須與保持獲利能力相容。
    • 悲觀情境:市場可能成長,但與擴張相關的經濟狀況將會惡化。
    • 敏感性分析識別的是經濟風險,而不是機率。
  • 對選定操作變更的最終敏感性
  • 功能性風險集中在核心應用和擴展類別。
    • 2036 年情境下價差的函數分佈
    • 地理暴露區分了絕對尺度和相對差異。
  • 2036 年情境下變異性的區域分佈
  • 可觀察的指標應該與它們可以改變的參數連結起來。
    • 從證據到決策的監測計劃
    • 按競爭叢集的策略重點
    • 買方和企業發展重點
    • 一項為期 12 至 24 個月的分階段行動計畫。
    • 風險範圍和解釋局限性
    • 最終策略結論

附錄A:收入的定義與報告標準

  • A.1 目標和市場範圍
  • A.2 功能定義
  • A.3 收入確認的定義
  • A.4 關於聚合和可比性的規則
  • A.5 單位、年份和貨幣
  • A.6 關於公式和分母的參考文獻

附錄B:地理範圍和會員資格

  • B.1 區域分配
  • B.2 國家和叢集構成
  • B.3 處理影響比較的邊界
  • B.4 過去的分配與不確定性

附錄C:主要假設、情境設計和證據局限性

  • C.1 過去的測量標準
  • C.2 預測結構和選定的通用做法
  • C.3預測中所採用的國別假設
  • 情境 C4 的前提條件
  • C.5 終端靈敏度是不同的檢驗方法。
  • C.6 證據和解釋的局限性
  • C.7說明和計算狀態

附錄 D:年度預測與資料配對指南

  • D.1 全球年度情景
  • D. 第二年數據手冊的範圍
  • D.3 如何使用表格
  • D.4 資料字典和空值

附錄E:公司和企業索引

  • E.1 如何使用此索引
  • E.2 參考競爭叢集
  • E.3 公司/企業名稱字母索引
  • E.4 與營業單位、所有權和範圍相關的條款

附錄F:框架解釋與商業術語

  • F.1框架閱讀指南
  • F.2 商業術語
  • F.3 視覺表徵的解釋
  • F.4 商業監控的定義
Product Code: MINTH-02107

Report Overview

This Marketstrat® Horizon Report analyzes the global enterprise imaging IT and picture archiving and communication systems (PACS) market from 2025 through 2036. It sizes and forecasts the software and directly attached services behind diagnostic viewing, image archiving, standalone RIS, radiology reporting, reader workflow, image exchange and patient access, and retained AI orchestration and governance.

The report ties the forecast to the decisions that set commercial outcomes: which application a customer replaces first, how a supplier earns additional scope, when contracted work becomes productive, and which payments survive renewal. Our view is that a first reader-platform award can open the way to later archive, reporting or workflow decisions, but a durable business still depends on accepted delivery and sustained payment. Independent suppliers need a continuing cross-system, service or specialized role as the customer's application environment changes.

Key Questions Answered

  • How does the first platform award shape the next purchase, and what should buyers settle on follow-on pricing, data access and exit terms at that first award?
  • What does a larger recurring contract actually represent once newly paid functionality, payments transferred from another supplier, and operating work moved into a managed service are separated?
  • Where can AI-assisted reporting and orchestration earn durable payment after substitution of earlier fees?
  • How should commercial strategy differ by country and by buyer type, from enterprise health systems to radiology groups and public imaging networks?
  • Which operating conditions separate the Base, Bull and Bear scenarios, and which signals should change the outlook?

Market Snapshot

The market is defined as external vendor revenue for common imaging applications and directly attached services, including vendor-bundled managed hosting. Clinical AI algorithms, dedicated specialty analytics, scanners and hardware, modality workstations, general EHR, professional interpretation and directly provider-paid infrastructure are excluded. Functional, revenue-recognition and geographic views describe the same revenue and reconcile to one defined total.

Growth depends on more than clinical demand. The forecast rests materially on the transition from legacy license economics to recurring contracts and on additional paid applications, alongside imaging activity, paid coverage and pricing. Because vendor receipts can rise when hosting moves into the contract or when one supplier absorbs another's fees, the report distinguishes growth in vendor revenue from net expansion in health-system spending.

Key Market Trends

  • 1. Core viewing and archives remain the commercial foundation. PACS and archive decisions carry the largest absolute opportunity, which keeps performance, interoperability, migration and support commercially consequential.
  • 2. Reporting brings more competitors into the reader's day. Established reporting suppliers, enterprise platforms, independent AI specialists and provider-origin businesses now compete for the same workflow, and the economics depend on whether new fees add to or replace existing ones.
  • 3. Recurring relationships carry more of the revenue. Subscriptions, committed usage and overages raise the importance of accepted billable activity, matched renewal pricing and retained paid modules.
  • 4. Modular entry can become a route to consolidation. A bounded viewer or workflow award can strengthen a supplier's position for the next archive decision.
  • 5. Managed hosting changes how growth should be read. Vendor receipts can increase as infrastructure responsibility moves into an application-service contract while the buyer's total operating cost moves differently.
  • 6. Delivery capacity sets the quality of growth. Wider contracts raise migration, support and integration obligations, so repeatable implementation becomes a competitive advantage.

Competitive Structure

Competition is organized into seven Competitive Clusters: enterprise imaging and diagnostic platform suppliers; locally integrated PACS/RIS and segment-focused suppliers; archive, interoperability, image access and common data workflow businesses; reporting, speech and reader-productivity suppliers; unified reader platforms and provider-origin technology businesses; AI orchestration, marketplace and governance platforms; and EHR, cloud and infrastructure adjacencies.

Each assessment covers the relevant buying decision, product and service scope, distribution position, implementation obligations and the conditions for retained payment. The report applies a Five Forces assessment and the GTM Growth–Maturity Matrix to selected participants. Coverage spans 62 company, business-unit, platform, historical-participant and adjacency spotlight entries, including Pro Medicus/Visage, Sectra, Agfa HealthCare, Fujifilm, Philips, GE HealthCare, Intelerad, Siemens Healthineers, Merge/Merative, Dedalus, INFINITT, Hyland, Mach7, Microsoft/Nuance, Rad AI, Sirona Medical, RadNet/DeepHealth, deepc, Incepto, CARPL.ai, Epic and Oracle Health.

What's Inside

Global market structure and outlook: Base, Bull and Bear scenarios with annual forecasts through 2036, by function, revenue-recognition stream and region.

Markintel® strategic frameworks: M³ Market Momentum Matrix, M-TEM Technology Evolution Matrix, T-DIC transition windows, Solution Adoption and Growth, Upgrade and Package Ladder, and Ecosystem Collaboration Matrix.

Company spotlights: 62 entries organized by Competitive Cluster, with cross-references and an alphabetical index.

Regional and country analysis: Five regions and 31 countries and analytical clusters, each tied to local purchasing, delivery and affordability conditions.

Commercialization and operating economics: Architecture choices, pricing references, minimums and overages, implementation acceptance, cloud procurement, reporting monetization and retention measures.

Strategic priorities: Sensitivities, signposts, priorities by Competitive Cluster and a staged 12–24-month action agenda.

Who Should Read This Report

  • Imaging-software, PACS and OEM executives and product leaders
  • Strategy, corporate-development and M&A teams
  • Investors and their advisors evaluating imaging IT businesses
  • Commercial and channel leaders planning market entry or account expansion
  • Health systems, radiology groups and imaging networks preparing platform, archive or reporting procurements
  • Consultants and advisory firms serving the imaging value chain

Why This Report

Few market studies separate new spending from transferred spending. This report does: it reconciles functional, recognition and geographic views to one revenue boundary, keeps clinical AI outside the core so totals are not double counted, and tests the assumptions that matter most to the conclusions. The company analysis is specific about the decision, buyer and geography behind each competitive claim, and the recommendations are staged so that larger commitments follow accepted deployment and retained payment.

Report Details

  • Title: Global Enterprise Imaging IT & PACS Horizon: Market Structure, Forecasts, Competitive Dynamics, and Workflow Monetization, 2025A–2036E
  • Report Type: Markintel® Horizon Report
  • Publisher: Marketstrat, Inc.
  • Publication Date: October 2026
  • Report ID: MINTH-02107
  • Base Year and Forecast Period: 2025A; 2025A–2036E
  • Length: 198 pages
  • Content: 97 tables and 34 figures
  • Format: PDF; Excel annual-data supplements available on request
  • Regional Coverage: North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
  • Country Coverage: 31 countries and analytical clusters
  • Competitive Coverage: 62 companies spotlighted across seven Competitive Clusters
  • License Options: Individual $4,750 | Team $5,250 | Enterprise $8,950

Table of Contents

SECTION 1: EXECUTIVE SUMMARY

  • 1.1 EXECUTIVE VIEW
  • 1.2 WHERE MARKET GROWTH CONCENTRATES
    • Global functional outlook
  • 1.3 THE COMMERCIAL MODEL CHANGES WITH THE DELIVERY OBLIGATION
    • Recurring relationships carry more of the revenue
    • Consolidation can proceed through selected replacements
    • Reporting and hosting change the interpretation of growth
  • 1.4 COMPETITIVE OUTLOOK: SEVEN CLUSTERS, OVERLAPPING BUYING DECISIONS
    • Competitive landscape at a glance
  • 1.5 GEOGRAPHIC PRIORITIES: PROTECT SCALE AND QUALIFY EXPANSION LOCALLY
    • Regional market outlook
  • 1.6 SCENARIOS AND RISKS: EXECUTION DETERMINES HOW MUCH OPPORTUNITY BECOMES REVENUE
    • Global scenario outlook
  • 1.7 EXECUTIVE IMPLICATIONS AND ACTIONS
  • 1.8 SIGNALS TO WATCH OVER THE NEXT 12–24 MONTHS
  • 1.9 SCOPE AND CONFIDENCE IN THE ESTIMATES
  • 1.10 EXECUTIVE CONCLUSION

SECTION 2: RESEARCH SCOPE, DEFINITIONS, AND METHODOLOGY

  • 2.1 PURPOSE AND MARKET DEFINITION
  • 2.2 REVENUE BOUNDARIES AND COUNTING RULES
  • 2.3 HISTORICAL MARKET CONSTRUCTION
  • 2.4 COUNTRY ALLOCATION AND ANNUAL GROWTH
  • 2.5 CONTRACT ECONOMICS AND ACTIVATION
  • 2.6 FUNCTIONAL AND RECOGNITION-STREAM VIEWS
  • 2.7 AI OVERLAP AND SPENDING TRANSFER
  • 2.8 SCENARIOS AND UNCERTAINTY
  • 2.9 EVIDENCE HANDLING AND ANALYTICAL RESPONSIBILITY
  • 2.10 INTERPRETATION

SECTION 3: GLOBAL MARKET STRUCTURE AND OUTLOOK

  • 3.1 MARKET OUTLOOK
    • Global market scenarios
  • 3.2 CORE VIEWING AND ARCHIVES RETAIN THE LARGEST ABSOLUTE OPPORTUNITY
    • Global functional market
  • 3.3 REPORTING COMPETITION CAN REDISTRIBUTE EXISTING SPENDING
  • 3.4 RECURRING RECOGNITION BECOMES MORE IMPORTANT
    • Revenue by recognition stream
  • 3.5 GEOGRAPHIC SCALE AND GROWTH REQUIRE DIFFERENT COMMERCIAL PRIORITIES
  • 3.6 SENSITIVITIES IDENTIFY THE MOST CONSEQUENTIAL OPERATING EXPOSURES
  • 3.7 STRATEGIC IMPLICATIONS
  • 3.8 GLOBAL CONCLUSION
  • 3.9 STRATEGIC THESIS: THE RENEWAL DECISION DETERMINES ACCESS TO A WIDER REVENUE POOL
  • 3.10 FRAMEWORK ARCHITECTURE AND DECISION USE
  • 3.11 M³ MARKET MOMENTUM MATRIX: SCALE AND GROWTH POINT TO DIFFERENT COMMERCIAL ROLES
    • Functional momentum and contribution to growth
  • 3.12 M-TEM: MATURE TECHNOLOGY CAN STILL HAVE AN IMMATURE DELIVERY MODEL
  • 3.13 T-DIC: THREE CONDITIONAL TRANSITION WINDOWS
  • 3.14 SOLUTION ADOPTION AND GROWTH: MATCH THE SELLING MOTION TO THE BUYER’S ACTUAL TASK
  • 3.15 REVENUE CREATION AND DISPLACEMENT: A NECESSARY COMMERCIAL BRIDGE
  • 3.16 CLOUD CONTRACTS: DISTINGUISH SUPPLIER REVENUE FROM THE CUSTOMER’S OPERATING BILL
  • 3.17 MARKINTEL UPGRADE & PACKAGE LADDER: SEQUENCE COMMITMENTS AROUND READINESS
  • 3.18 ECOSYSTEM COLLABORATION: PARTNERSHIP VALUE DEPENDS ON OPERATING RESPONSIBILITY
  • 3.19 STRATEGIC ROBUSTNESS: ACTIONS THAT REMAIN USEFUL ACROSS THE SCENARIOS

SECTION 4: COMPETITIVE CLUSTERS, COMPANY SPOTLIGHTS AND COMMERCIAL STRATEGY

  • 4.1 COMPETITIVE THESIS: CONTROL IS DISTRIBUTED ACROSS THE IMAGING WORKFLOW
  • 4.2 COMPETITIVE CLUSTERS AND COMPANY COVERAGE
    • Competitive cluster map and covered participants
  • 4.3 HISTORICAL REVENUE SCALE: USEFUL CONTEXT, LIMITED RANKING PRECISION
    • Selected historical eligible-core revenue estimates
  • 4.4 WHY COMPETITIVE POSITIONS ARE DIFFICULT TO DISPLACE, AND WHERE ENTRY REMAINS POSSIBLE
  • 4.5 GTM GROWTH–MATURITY MATRIX: SELECTIVE COMPANY PLACEMENTS
    • Competitive dataset and placement rationale
    • Competitive context and growth–maturity highlights
  • 4.6 COMPETITIVE CLUSTER 1: ENTERPRISE IMAGING AND DIAGNOSTIC PLATFORM SUPPLIERS
    • 4.6.1 Pro Medicus / Visage: the reader environment supports expansion, but each module needs a paid decision
    • 4.6.2 Sectra: enterprise scope increases strategic influence and operating obligations
    • 4.6.3 Agfa HealthCare: the quality of conversion matters more than the cloud-order label
    • 4.6.4 Philips: a substantial informatics platform needs an imaging-specific commercial account
    • 4.6.5 Fujifilm: breadth and local position support scale, but revenue scope remains important
    • 4.6.6 GE HealthCare legacy imaging IT: continuity of the installed business remains a distinct commercial task
    • 4.6.7 Intelerad: an acquired application platform with its own operating history
    • 4.6.8 Siemens Healthineers: define the software objective independently of scanner relationships
    • 4.6.9 Merge: current cloud development prevents a simple incumbent-versus-cloud narrative
  • 4.7 COMPETITIVE CLUSTER 2: LOCALLY INTEGRATED PACS/RIS AND SEGMENT-FOCUSED SUPPLIERS
    • 4.7.1 Dedalus imaging IT: local workflow supports the enterprise relationship
    • 4.7.2 INFINITT: global application revenue requires a global competitive lens
    • 4.7.3 TechMatrix / PSP: cloud packaging changes the unit of purchase
    • 4.7.4 Telemis: local execution can preserve value in a broad platform market
    • 4.7.5 Neagen / Vitec: local imaging expertise and group scale are separate measures
    • 4.7.6 IMEXHS: the separation of software and professional reading is commercially decisive
    • 4.7.7 Konica Minolta imaging IT: integration and specialist partnerships coexist
    • 4.7.8 Canon Medical imaging IT: shared image management deserves separate treatment from specialty analysis
    • 4.7.9 RamSoft: a complete workflow proposition for defined operating environments
    • 4.7.10 Novarad: preserve the common-imaging perimeter within a broader portfolio
    • 4.7.11 CGM / VISUS: JiveX belongs in the imaging comparison independently of the parent EHR business
    • 4.7.12 NEXUS / CHILI: evaluate the imaging business at the application level
    • 4.7.13 Softway Medical imaging: distinguish the local imaging franchise from general hospital software
    • 4.7.14 Maincare: retained application and integration value must be separated from pass-through
    • 4.7.15 PaxeraHealth: breadth must become repeatable deployment
    • 4.7.16 IMAGE Information Systems: an application specialist can remain relevant in bounded replacements
    • 4.7.17 Neusoft imaging software: identify the software entity before interpreting scale
    • 4.7.18 Winning: a named local-supplier example with a deliberately limited financial claim
    • 4.7.19 B-Soft: local healthcare-IT context requires an imaging-specific boundary
    • 4.7.20 Xunfei imaging activity: identity and product scope remain bounded
    • 4.7.21 TechHeim: an identifiable Korean PACS participant without an inferred share
    • 4.7.22 Medsynaptic: alternative delivery configurations support a distinct commercialization model
    • 4.7.23 Pixeon: regional integration and modular imaging are relevant to Brazilian procurement
    • 4.7.24 MV imaging: integrated clinical software requires disciplined revenue allocation
    • 4.7.25 AKGUN imaging: interinstitutional capability should be separated from geographic revenue attribution
    • 4.7.26 Lifetrack Medical Systems: distributed reading requires a supportable application configuration
    • 4.7.27 BMD Software / PACScenter: web-based imaging spans provider and network configurations
  • 4.8 COMPETITIVE CLUSTER 3: ARCHIVE, INTEROPERABILITY, IMAGE ACCESS AND COMMON DATA WORKFLOW
    • 4.8.1 Hyland
    • 4.8.2 Mach7
    • 4.8.3 Optum / Change legacy imaging: continuity and ownership labels must not obscure product scope
    • 4.8.4 Enlitic common data workflow: difficult data work can remain valuable through platform replacement
    • 4.8.5 PocketHealth: access adoption and paid adoption have different denominators
  • 4.9 COMPETITIVE CLUSTER 4: REPORTING, SPEECH AND READER-PRODUCTIVITY SUPPLIERS
    • 4.9.1 Microsoft / Nuance: an active incumbent with a substantial reporting position
    • 4.9.2 Rad AI: independent reporting must retain value through incumbent response
    • 4.9.3 Solventum radiology reporting: a specialist perimeter inside a wider software business
    • 4.9.4 NewVue: reader operations can be sold through a platform partner
    • 4.9.5 New Lantern: distinguish the platform proposition from the evidence of paid scale
    • 4.9.6 RADPAIR: an identifiable reporting participant within the smaller-supplier pool
    • 4.9.7 nVoq: a speech-technology partner with a narrower role than the contracted imaging platform
  • 4.10 COMPETITIVE CLUSTER 5: UNIFIED READER PLATFORMS AND PROVIDER-ORIGIN TECHNOLOGY BUSINESSES
    • 4.10.1 Sirona: the international contract is strategically significant, while activation remains the test
    • 4.10.2 RadNet / DeepHealth: internal experience and external demand require separate accounts
    • 4.10.3 Mosaic / Radiology Partners: internal scale provides a development environment, not an external revenue total
  • 4.11 COMPETITIVE CLUSTER 6: AI ORCHESTRATION, MARKETPLACE AND GOVERNANCE PLATFORMS
    • 4.11.1 deepc: retained governance requires an operating proposition after integration
    • 4.11.2 Incepto: distribution and service economics must be separated from gross application resale
    • 4.11.3 CARPL.ai: catalog breadth needs a paid governance counterpart
    • 4.11.4 Ferrum Health: implementation evidence is useful only with the correct denominator
    • 4.11.5 Aidoc’s eligible platform activity: broader clinical reach is not the core-market denominator
    • 4.11.6 Bayer / Blackford: a historical case in platform durability
  • 4.12 COMPETITIVE CLUSTER 7: EHR, CLOUD AND INFRASTRUCTURE ADJACENCIES
    • 4.12.1 Epic: EHR workflow influences imaging procurement without defining the entire imaging contract
    • 4.12.2 Oracle Health: EHR adjacency and a marketed PACS offering require a dual treatment
    • 4.12.3 Amazon Web Services: infrastructure can shape the application economics without replacing the application
    • 4.12.4 Microsoft Azure: separate the infrastructure relationship from Nuance application revenue
    • 4.12.5 Google Cloud: interoperable data services are an enabling layer
  • 4.13 FIVE COMPETITIVE CASES THAT CHANGE COMMERCIAL INTERPRETATION
  • 4.14 COMPETITIVE POSITIONS THAT WOULD STRENGTHEN OR WEAKEN THE THESIS
  • 4.15 COMMERCIAL PRIORITIES BY PARTICIPANT
  • 4.16 A PRACTICAL COMPETITIVE DASHBOARD
  • 4.17 COMPETITIVE CONCLUSION

SECTION 5: REGIONAL AND COUNTRY MARKET ANALYSIS

  • 5.1 REGIONAL SCALE AND THE LOCAL MECHANISMS OF COMMERCIALIZATION
    • Regional market outlook
    • Absolute growth and the changing Asia-Pacific mix
    • How to interpret the country analysis
    • Regional commercialization archetypes
  • 5.2 NORTH AMERICA
    • Regional scenario reference
    • 5.2.1 United States
    • 5.2.2 Canada
  • 5.3 EUROPE
    • 5.3.1 Germany
    • 5.3.2 France
    • 5.3.3 United Kingdom
    • 5.3.4 Italy
    • 5.3.5 Spain
    • 5.3.6 Republic of Ireland
    • 5.3.7 Nordics
    • 5.3.8 Benelux
    • 5.3.9 Central / Eastern Europe
    • 5.3.10 Rest of Europe
  • 5.4 ASIA-PACIFIC
    • Regional scenario reference
    • 5.4.1 Mainland China
    • 5.4.2 Japan
    • 5.4.3 India
    • 5.4.4 South Korea
    • 5.4.5 Australia
    • 5.4.6 New Zealand
    • 5.4.7 Singapore / Taiwan
    • 5.4.8 Southeast Asia ex-Singapore
    • 5.4.9 South Asia ex-India
    • 5.4.10 Other Asia-Pacific
  • 5.5 LATIN AMERICA
    • Regional scenario reference
    • 5.5.1 Brazil
    • 5.5.2 Mexico
    • 5.5.3 Rest of Latin America
  • 5.6 MIDDLE EAST & AFRICA
    • Regional scenario reference
    • 5.6.1 Saudi Arabia
    • 5.6.2 United Arab Emirates
    • 5.6.3 Rest of GCC
    • 5.6.4 South Africa
    • 5.6.5 North Africa
    • 5.6.6 Rest of Middle East / Africa
  • 5.7 CROSS-REGIONAL STRATEGIC SYNTHESIS
    • Image availability and application replacement must be evaluated separately
    • Local suppliers change the attainable package, not merely the headline price
    • Scale and growth require a two-part resource decision
    • Evidence that would change the geographic interpretation
  • 5.8 GEOGRAPHIC CONCLUSION

SECTION 6: TECHNOLOGY, COMMERCIALIZATION AND OPERATING ECONOMICS

  • 6.1 COMMERCIAL THESIS: THE DELIVERY OBLIGATION DETERMINES THE QUALITY OF GROWTH
  • 6.2 ARCHITECTURE SELECTION SHOULD START WITH THE REPLACEMENT BOUNDARY
    • Architecture choice and the obligation it creates
  • 6.3 BUYER-SPECIFIC CONFIGURATIONS DETERMINE THE SELLING MOTION
  • 6.4 PRICING REFERENCES NEED A COMMON SCOPE BEFORE THEY BECOME BENCHMARKS
    • Selected contract references and their interpretation
  • 6.5 MINIMUMS AND OVERAGES ALLOCATE DEMAND RISK
  • 6.6 FOUR COMMERCIAL CLOCKS EXPLAIN WHY CONTRACT VALUE AND REVENUE DIFFER
  • 6.7 IMPLEMENTATION SHOULD BE MANAGED AS A PORTFOLIO OF ACCEPTED WORKLOADS
    • Recommended implementation acceptance schedule
  • 6.8 CLOUD PROCUREMENT NEEDS TWO ECONOMIC SCHEDULES
    • Match the buyer obligation to the supplier obligation
  • 6.9 REPORTING MONETIZATION REQUIRES A POST-TRANSITION SPENDING TEST
  • 6.10 PAID-MODULE ATTACHMENT SHOULD BE EVALUATED AT RENEWAL
  • 6.11 INDEPENDENT ORCHESTRATION NEEDS A FUNDED CONTINUING ROLE
  • 6.12 INTEROPERABILITY, SERVICE CONTINUITY AND GOVERNANCE HAVE CONTRACT-LEVEL CONSEQUENCES
  • 6.13 RETENTION AND UNIT ECONOMICS SHOULD BE ASSESSED ON A MATCHED CUSTOMER BASE
    • Proposed measures for operating review
  • 6.14 COMMERCIALIZATION PRIORITIES BY COMPETITIVE CLUSTER
  • 6.15 SECTION CONCLUSION

SECTION 7: SCENARIO OUTLOOK, STRATEGIC PRIORITIES AND ACTION AGENDA

  • 7.1 STRATEGIC THESIS: PACE COMMITMENTS AGAINST THE CONDITIONS REQUIRED FOR REVENUE
    • Global market scenarios
  • 7.2 THE SCENARIOS CHANGE OPERATING CONDITIONS, NOT THE HISTORICAL DENOMINATOR
    • Principal operating assumptions that distinguish the scenarios
    • 7.3 BASE CASE: COORDINATED EXECUTION CREATES A LARGER RECURRING MARKET
    • 7.4 BULL CASE: FASTER IMPLEMENTATION MUST COINCIDE WITH RETAINED MONETIZATION
    • 7.5 BEAR CASE: A MARKET CAN GROW WHILE EXPANSION ECONOMICS DETERIORATE
    • 7.6 SENSITIVITIES IDENTIFY ECONOMIC EXPOSURE, NOT PROBABILITIES
  • Terminal sensitivity to selected operating changes
  • 7.7 FUNCTIONAL EXPOSURE CONCENTRATES IN BOTH CORE APPLICATIONS AND EXPANSION CATEGORIES
    • Functional distribution of the 2036 scenario spread
    • 7.8 GEOGRAPHIC EXPOSURE SEPARATES ABSOLUTE SCALE FROM RELATIVE DISPERSION
  • Regional distribution of the 2036 scenario spread
  • 7.9 OBSERVABLE SIGNPOSTS SHOULD BE TIED TO THE PARAMETER THEY CAN CHANGE
    • Evidence-to-decision monitoring schedule
    • 7.10 STRATEGIC PRIORITIES BY COMPETITIVE CLUSTER
    • 7.11 BUYER AND CORPORATE-DEVELOPMENT PRIORITIES
    • 7.12 A STAGED 12–24-MONTH ACTION AGENDA
    • 7.13 RISK BOUNDARIES AND INTERPRETATION LIMITS
    • 7.14 FINAL STRATEGIC CONCLUSION

APPENDIX A: REVENUE DEFINITIONS AND REPORTING CONVENTIONS

  • A.1 PURPOSE AND MARKET BOUNDARY
  • A.2 FUNCTIONAL DEFINITIONS
  • A.3 REVENUE-RECOGNITION DEFINITIONS
  • A.4 COUNTING AND COMPARABILITY RULES
  • A.5 UNITS, YEARS AND CURRENCY
  • A.6 FORMULA AND DENOMINATOR REFERENCE

APPENDIX B: GEOGRAPHIC COVERAGE AND MEMBERSHIP

  • B.1 GEOGRAPHIC ALLOCATION
  • B.2 COUNTRY AND CLUSTER MEMBERSHIP
  • B.3 BOUNDARY CONVENTIONS THAT AFFECT COMPARISON
  • B.4 HISTORICAL ALLOCATION AND UNCERTAINTY

APPENDIX C: SELECTED ASSUMPTIONS, SCENARIO DESIGN AND EVIDENCE LIMITS

  • C.1 HISTORICAL MEASUREMENT BASIS
  • C.2 FORECAST STRUCTURE AND SELECTED COMMON CONVENTIONS
  • C.3 COUNTRY ASSUMPTIONS RETAINED IN THE FORECAST
  • C.4 SCENARIO ASSUMPTIONS
  • C.5 TERMINAL SENSITIVITIES ARE A DIFFERENT TEST
  • C.6 EVIDENCE AND INTERPRETATION LIMITS
  • C.7 STATUS OF STATEMENTS AND CALCULATIONS

APPENDIX D: ANNUAL FORECASTS AND DATA-COMPANION GUIDE

  • D.1 GLOBAL ANNUAL SCENARIOS
  • D.2 COVERAGE OF THE ANNUAL DATA COMPANION
  • D.3 HOW TO USE THE TABLES
  • D.4 DATA DICTIONARY AND EMPTY VALUES

APPENDIX E: COMPANY AND BUSINESS INDEX

  • E.1 HOW TO USE THIS INDEX
  • E.2 COMPETITIVE CLUSTER REFERENCE
  • E.3 ALPHABETICAL COMPANY/BUSINESS INDEX
  • E.4 ENTITY, OWNERSHIP AND SCOPE CONVENTIONS

APPENDIX F: FRAMEWORK INTERPRETATION AND COMMERCIAL TERMINOLOGY

  • F.1 FRAMEWORK READING GUIDE
  • F.2 COMMERCIAL TERMINOLOGY
  • F.3 INTERPRETATION OF VISUAL FORMS
  • F.4 COMMERCIAL MONITORING DEFINITIONS

List of Tables

  • TABLE 1: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE BY FUNCTION, 2025A AND 2036E (BASE CASE, US$ MILLION)
  • TABLE 2: ENTERPRISE IMAGING IT & PACS COMPETITIVE LANDSCAPE: EXECUTIVE CLUSTER SUMMARY
  • TABLE 3: REGIONAL ENTERPRISE IMAGING IT & PACS REVENUE AND GROWTH CONTRIBUTIONS, 2025A–2036E (BASE CASE, US$ MILLION)
  • TABLE 4: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS AND OPERATING CONDITIONS, 2025A–2036E (US$ BILLION)
  • TABLE 5: EXECUTIVE PRIORITIES AND CONDITIONS FOR LARGER COMMITMENTS BY STAKEHOLDER
  • TABLE 6: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E (US$ BILLION)
  • TABLE 7: ATTRIBUTION OF THE MODELED GLOBAL REVENUE INCREASE, 2025A–2036E
  • TABLE 8: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE BY FUNCTION, 2025A, 2030E AND 2036E (BASE CASE; US$ MILLION)
  • TABLE 9: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE BY RECOGNITION STREAM, 2025A, 2030E AND 2036E (US$ MILLION; BASE CASE)
  • TABLE 10: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE BY REGION, 2025A, 2030E AND 2036E (US$ MILLION; BASE CASE)
  • TABLE 11: MARKINTEL® STRATEGIC FRAMEWORKS: DECISION USES, ANALYTICAL BASES AND INTERPRETATION LIMITS
  • TABLE 12: M³ MARKET MOMENTUM MATRIX: FUNCTIONAL SCALE, GROWTH AND POSITIONING, 2025A–2036E (US$ MILLION; BASE CASE)
  • TABLE 13: FUNCTIONAL REVENUE GROWTH BY SCENARIO, 2025A–2036E
  • TABLE 14: FUNCTIONAL ALLOCATION SENSITIVITY AT AN UNCHANGED GLOBAL MARKET, 2036E
  • TABLE 15: M-TEM TECHNOLOGY EVOLUTION MATRIX: CAPABILITY MATURITY AND COMMERCIAL CONSTRAINTS
  • TABLE 16: T-DIC: CONDITIONAL TECHNOLOGY AND COMMERCIALIZATION TRANSITIONS, 2026–2036
  • TABLE 17: SOLUTION ADOPTION & GROWTH: USE-CASE POSITIONING AND COMMERCIAL TESTS
  • TABLE 18: CLOUD CONTRACT COMPARISON: SCOPE, OPERATING RESPONSIBILITIES AND ECONOMICS
  • TABLE 19: UPGRADE & PACKAGE LADDER: SCOPE, READINESS AND COMMERCIAL DISCIPLINE
  • TABLE 20: ECOSYSTEM COLLABORATION MATRIX: RELATIONSHIP TYPES, STRATEGIC VALUE AND OPERATING TESTS
  • TABLE 21: SCENARIO-RESILIENT PRIORITIES AND CONDITIONS FOR LARGER COMMITMENTS
  • TABLE 22: ENTERPRISE IMAGING IT & PACS COMPETITIVE CLUSTERS AND COMPANY COVERAGE
  • TABLE 23: SELECTED SUPPLIER COMMON-IMAGING REVENUE ESTIMATES AND JUDGMENTAL RANGES, 2025A US$ MILLION; ALPHABETICAL PRESENTATION
  • TABLE 24: FIVE FORCES IN ENTERPRISE IMAGING IT & PACS: ASSESSMENT AND COMMERCIAL IMPLICATIONS
  • TABLE 25: GTM GROWTH–MATURITY MATRIX: SELECTED COMPANY PLACEMENTS, EVIDENCE AND COUNTERWEIGHTS
  • TABLE 26: FIVE COMPETITIVE CASES: SUPPORTED INTERPRETATIONS AND STRATEGIC CONSEQUENCES
  • TABLE 27: COMPETITIVE THESIS TESTS: EVIDENCE THAT WOULD STRENGTHEN OR WEAKEN CURRENT JUDGMENTS
  • TABLE 28: COMPETITIVE MONITORING DASHBOARD: PROPOSED MEASURES, DEFINITIONS AND INTERPRETATION ERRORS
  • TABLE 29: REGIONAL ENTERPRISE IMAGING IT & PACS REVENUE OUTLOOK AND GLOBAL GROWTH CONTRIBUTIONS, 2025A– 2036E (US$ MILLION; BASE CASE)
  • TABLE 30: TOP FIVE COUNTRY AND CLUSTER CONTRIBUTIONS TO GLOBAL REVENUE GROWTH, 2025A–2036E (BASE CASE)
  • TABLE 31: REGIONAL COMMERCIALIZATION ARCHETYPES: ESTABLISHED REVENUE POOLS AND COVERAGE EXPANSION
  • TABLE 32: NORTH AMERICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 33: UNITED STATES ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 34: CANADA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 35: EUROPE ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 36: GERMANY ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 37: FRANCE ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 38: UNITED KINGDOM ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 39: ITALY ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 40: SPAIN ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 41: REPUBLIC OF IRELAND ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 42: NORDICS ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 43: BENELUX ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 44: CENTRAL/EASTERN EUROPE ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 45: REST OF EUROPE ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 46: ASIA-PACIFIC ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 47: MAINLAND CHINA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 48: JAPAN ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 49: INDIA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 50: SOUTH KOREA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 51: AUSTRALIA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 52: NEW ZEALAND ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 53: SINGAPORE/TAIWAN ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 54: SOUTHEAST ASIA EX-SINGAPORE ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 55: SOUTH ASIA EX-INDIA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 56: OTHER ASIA-PACIFIC ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 57: LATIN AMERICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 58: BRAZIL ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 59: MEXICO ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 60: REST OF LATIN AMERICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 61: MIDDLE EAST & AFRICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 62: SAUDI ARABIA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 63: UNITED ARAB EMIRATES ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 64: REST OF GCC ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 65: SOUTH AFRICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 66: NORTH AFRICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 67: REST OF MIDDLE EAST / AFRICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 68: GEOGRAPHIC FORECAST SIGNPOSTS: OBSERVATIONS, INTERPRETATIONS AND REVISION DISCIPLINE
  • TABLE 69: ARCHITECTURE CHOICES: BUYER PROBLEMS, OPERATING OBLIGATIONS AND ACCEPTANCE TESTS
  • TABLE 70: BUYER-SPECIFIC COMMERCIAL CONFIGURATIONS AND CONDITIONS FOR PAID EXPANSION
  • TABLE 71: SELECTED IMAGING-IT CONTRACTS: COMMITMENTS, TERMS AND ANNUALIZED REFERENCES
  • TABLE 72: IMPLEMENTATION ACCEPTANCE FRAMEWORK: DELIVERABLES, EVIDENCE AND COMMERCIAL CONSEQUENCES
  • TABLE 73: CLOUD OPERATING ECONOMICS: MATCHED BUYER AND SUPPLIER RESPONSIBILITIES
  • TABLE 74: PROPOSED RETENTION AND UNIT-ECONOMICS MEASURES FOR OPERATING REVIEW
  • TABLE 75: COMMERCIALIZATION PRIORITIES AND CONDITIONS FOR EXPANSION BY COMPETITIVE CLUSTER
  • TABLE 76: GLOBAL ENTERPRISE IMAGING IT & PACS SCENARIOS AND TERMINAL DIFFERENCES FROM BASE, 2025A–2036E, US$ BILLION
  • TABLE 77: PRINCIPAL OPERATING ASSUMPTIONS BY SCENARIO
  • TABLE 78: ONE-AT-A-TIME SENSITIVITY OF GLOBAL REVENUE TO SELECTED OPERATING CHANGES, US$ MILLION, EXCEPT PERCENTAGES
  • TABLE 79: FUNCTIONAL REVENUE SCENARIOS AND CONTRIBUTIONS TO THE BULL–BEAR SPREAD, 2036E, US$ MILLION
  • TABLE 80: REGIONAL REVENUE SCENARIOS AND ABSOLUTE AND RELATIVE DISPERSION, 2036E
  • TABLE 81: FORECAST MONITORING: REQUIRED EVIDENCE AND THE ASSUMPTIONS IT CAN CHANGE
  • TABLE 82: STRATEGIC PRIORITIES, CONDITIONAL COMMITMENTS AND RISKS BY COMPETITIVE CLUSTER
  • TABLE 83: RECOMMENDED 12–24-MONTH ACTION AGENDA: DECISIONS, RESPONSIBILITIES AND EVIDENCE
  • TABLE 84: COMMON-IMAGING FUNCTIONAL DEFINITIONS AND SCOPE BOUNDARIES
  • TABLE 85: REVENUE-RECOGNITION STREAM DEFINITIONS AND INTERPRETATION
  • TABLE 86: REVENUE COUNTING AND COMPARABILITY RULES
  • TABLE 87: FORMULA AND DENOMINATOR REFERENCE: DEFINITIONS AND INTERPRETATION LIMITS
  • TABLE 88: GEOGRAPHIC COVERAGE: COUNTRY AND CLUSTER MEMBERSHIP AND BOUNDARIES
  • TABLE 89: SELECTED COUNTRY AND CLUSTER ASSUMPTIONS: STUDY GROWTH, PAID COVERAGE AND RENEWAL EXPOSURE
  • TABLE 90: SCENARIO ASSUMPTIONS: DEMAND, CONVERSION, PRICING, MODULES AND SERVICE PARAMETERS
  • TABLE 91: EVIDENCE LIMITATIONS AND REQUIRED INTERPRETATION BY ANALYTICAL AREA
  • TABLE 92: GLOBAL ENTERPRISE IMAGING IT & PACS ANNUAL REVENUE SCENARIOS, 2025A–2036E, US$ BILLION
  • TABLE 93: ANNUAL DATA COMPANION: FORECAST SCHEDULE COVERAGE AND OBSERVATION COUNTS
  • TABLE 94: COMPETITIVE CLUSTER DEFINITIONS AND SPOTLIGHT COUNTS
  • TABLE 95: COMPANY AND BUSINESS INDEX: PRINCIPAL COMPETITIVE CLUSTER AND SPOTLIGHT LOCATION
  • TABLE 96: MARKINTEL FRAMEWORK READING GUIDE: DIMENSIONS, APPLICATIONS AND INTERPRETATION LIMITS
  • TABLE 97: ENTERPRISE IMAGING IT & PACS COMMERCIAL GLOSSARY

List of Figures

  • FIGURE 1: FASTER EXPANSION DOES NOT DISPLACE THE CORE
  • FIGURE 2: RECURRING MIX DEPENDS ON THE ALLOCATION CONVENTION
  • FIGURE 3: DIFFERENT GROWTH ROUTES FACE THE SAME PROOF TEST
  • FIGURE 4: SCALE AND LOCAL DELIVERY SET GEOGRAPHIC PRIORITIES
  • FIGURE 5: ONE REVENUE BOUNDARY, SEVERAL MARKET VIEWS
  • FIGURE 6: COUNTRY ALLOCATION PRESERVES THE RAW BUYER ESTIMATE
  • FIGURE 7: FUNCTIONAL CONTRIBUTIONS TO GLOBAL MARKET GROWTH
  • FIGURE 8: FUNCTIONAL MOMENTUM DEPENDS ON ALLOCATION
  • FIGURE 9: TECHNICAL MATURITY CAN EXCEED DELIVERY READINESS
  • FIGURE 10: COMMERCIAL IMPACT DEPENDS ON REPEATABLE DELIVERY
  • FIGURE 11: PAID SCOPE MUST SURVIVE ACTIVATION AND RENEWAL
  • FIGURE 12: EVERY UPGRADE REQUIRES NEW OPERATING PROOF
  • FIGURE 13: PARTNERSHIP VALUE DEPENDS ON OPERATING RESPONSIBILITY
  • FIGURE 14: SEVEN CLUSTERS MEET AT THE BUYER’S NEXT DECISION
  • FIGURE 15: BROAD REVENUE RANGES LIMIT SUPPLIER RANKINGS
  • FIGURE 16: GROWTH AND EXECUTION CREATE DIFFERENT POSITIONS
  • FIGURE 17: FOUR ROUTES COMPETE FOR THE READER RELATIONSHIP
  • FIGURE 18: A PARTIAL AWARD CAN BECOME A FULL-STACK CONTRACT
  • FIGURE 19: FAST GROWTH IS NOT THE SAME AS LARGE OPPORTUNITY
  • FIGURE 20: US SCALE DOMINATES; CANADIAN BUYING STAYS DISTINCT
  • FIGURE 21: EUROPE’S GROWTH EXTENDS BEYOND ITS LARGEST MARKET
  • FIGURE 22: INDIA AND SOUTHEAST ASIA GAIN ASIA-PACIFIC SHARE
  • FIGURE 23: BRAZIL ANCHORS GROWTH; LOCAL DELIVERY SHAPES ACCESS
  • FIGURE 24: GULF MARKETS ANCHOR A DIVERSE MEA OPPORTUNITY
  • FIGURE 25: SHARED IMAGE ACCESS NEED NOT REPLACE THE PACS
  • FIGURE 26: MINIMUMS PROTECT RECEIPTS; OVERAGES ADD ABOVE THE FLOOR
  • FIGURE 27: A CONTRACT HAS FOUR CLOCKS, NOT ONE REVENUE DATE
  • FIGURE 28: VENDOR GROWTH AND BUYER COSTS ARE DIFFERENT QUESTIONS
  • FIGURE 29: REPORTING CAN MOVE RECEIPTS WITHOUT MARKET GROWTH
  • FIGURE 30: RETAINED PLATFORM FEES MUST FUND THE OPERATING ROLE
  • FIGURE 31: EXECUTION SEPARATES THE THREE GROWTH PATHS
  • FIGURE 32: SENSITIVITY DEPENDS ON THE OPERATING CHANGE TESTED
  • FIGURE 33: ALLOCATION CHANGES WHERE SCENARIO DISPERSION SITS
  • FIGURE 34: PROTECT THE BASE; MAKE EXPANSION CONDITIONAL